4.2 Article

Impact of regulatory polymorphisms in organic anion transporter genes in the human liver

Journal

PHARMACOGENETICS AND GENOMICS
Volume 19, Issue 8, Pages 647-656

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/FPC.0b013e32832fabd3

Keywords

indocyanine green; multidrug resistance-associated protein 2; organic anion transporting polypeptide; promoter regulatory single nucleotide polymorphism

Funding

  1. Ministry of Education, Culture, Sports, Science and Technology of Japan
  2. Takeda Science foundation
  3. Japan Society for the Promotion of Science

Ask authors/readers for more resources

Objectives The aim of this study was to evaluate whether genetic polymorphisms are responsible for individual variation in the expression levels of hepatic organic anion transporters. Methods The mRNA levels of multidrug resistance-associated protein 2, organic anion transporting polypeptide (OATP) 1B1, OATP1B3 and OATP2B1 were determined by real-time polymerase chain reaction using liver tissue samples from 102 Japanese. The association between the mRNA levels of these transporters and the disappearance rate of indocyanine green was examined. The promoter region of each transporter gene was sequenced and the effects of single nucleotide polymorphisms (SNPs) in the promoter region [regulatory SNPs (rSNPs)] on mRNA levels were evaluated. Western blot analysis using hepatic crude plasma membrane was carried out to assess protein levels. Results Expression levels of hepatic organic anion transporters vary considerably among individuals and possible links were observed between mRNA levels of these transporters and the disappearance rate of indocyanine green. In the OATP2B1 promoter region, we identified an rSNP (- 282G > A) that significantly increased mRNA expression. Western blot analysis showed a remarkable increase in the OATP2B1 protein level in the homozygotes for the rSNP with a high mRNA level. In contrast, none of the rSNPs of multidrug resistance-associated protein 2, OATP1B1 and OATP1B3 affected the mRNA expression. Conclusion OATP2B1 - 282G > A is a major factor affecting expression, suggesting a contribution to inter-individual differences in the expression level of OATP2B1. Pharmacogenetics and Genomics 19:647-656 (C) 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available